Genetic Technology News

摘要

Biogen Idee Antibody Is Potential MS Therapeutic; Gene Expression Profile to Find ALS Drug Targets; GTN Strategic Partners; Some Important Patents for You To Check; CHEMOCENTRYX RECEPTOR CONTROLS TUMOR GROWTH; INHIBITING FATTY Aero SYNTHASE KILLS CANCER CELLS: Fatty acid synthase (FAS) is a key enzyme in the fat biosynthesis pathway, which is essential for the body to produce fat and to regulate energy. Some time ago the researchers who founded FASgen Inc. discovered that FAS plays a different role in a cancer cell, which does not produce fat. It acts to regulate the energy source that keeps the cell alive. They found that inhibiting FAS kills the cancer cell. Since then many others have confirmed this. FASgen has developed a number of compounds toinhibit FAS and has intellectual property covering them and their use. The compounds, led by FAS031, have demonstrated efficacy against every solid tumor xenograft cell line tested in animal models.